Enables chromatin binding activity; nuclear receptor binding activity; and nuclear receptor coactivator activity. Acts upstream of or within positive regulation of transcription by RNA polymerase II. Predicted to be located in cytoplasmic vesicle; cytoskeleton; and endoplasmic reticulum. Predicted to be active in nucleus. Is expressed in cranial ganglion and urethra. Orthologous to human SLC30A9 (solute carrier family 30 member 9). [provided by Alliance of Genome Resources, Apr 2022]